Dirige, Krissa May B.
HRN: 23-63-46 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/13/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
10/13/2023
10/16/2023
IV
500mg
Q8H X 7 Doses
S/p LTCS
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes